ImmunityBio Shares Surge 471% as Potential Short Squeeze Looms

Shares of ImmunityBio (IBRX) have witnessed an extraordinary rally, surging by 471% in a massive upward move. Market analysts are now closely monitoring the stock for a potential short squeeze that could further accelerate these gains. This scenario arises as short sellers face mounting pressure to cover their positions following the significant price appreciation. If these sellers are forced to capitulate, the resulting buying volume could drive the stock to even higher levels. The biotech firm's recent performance has attracted significant attention from retail and institutional investors alike. Consequently, high volatility is expected as the market tests the resilience of current short positions.